Cardiogenic ShockSymptoms, Doctors, Treatments, Advances & More
Learn About Cardiogenic Shock
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Rutgers Health-Rwj Scleroderma Program
Maya Guglin is a Cardiologist and a Transplant Surgeon practicing medicine in New Brunswick, New Jersey. Dr. Guglin is rated as an Elite provider by MediFind in the treatment of Cardiogenic Shock. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Heart Failure, Cardiogenic Shock, Cardiomyopathy, Heart Transplant, and Lung Transplant. Dr. Guglin is currently accepting new patients.
University Of Texas Southwestern Medical Center At Dallas
Maryjane Farr is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Dallas, Texas. Dr. Farr is rated as an Elite provider by MediFind in the treatment of Cardiogenic Shock. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Heart Failure, Cardiogenic Shock, Cardiomyopathy, Pulmonary Edema, and Heart Transplant.
Tufts Medical Center Cardiology
Navin Kapur is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Kapur is rated as an Elite provider by MediFind in the treatment of Cardiogenic Shock. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Heart Attack, Heart Failure, Heart Transplant, and Percutaneous Coronary Intervention (PCI).
Summary: The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units
Summary: The purpose of this study is to better understand the time course of different biological mechanisms involved in acute decompensated heart failure complicated by cardiogenic shock throughout the evaluation of changes and the relationship among markers of inflammation (IL-6) and markers of increased endothelial permeability (Ang-2) or endothelial glycocalyx perturbation (Syndecan-1 and HS) and thro...